Skip to main content

Advertisement

ADVERTISEMENT

News

News
02/02/2023
CLEVELAND — The International Cardio-Oncology Society has awarded University Hospitals (UH) Harrington Heart & Vascular Institute a Center of Excellence designation in recognition of its ongoing support of cancer patients facing heart...
CLEVELAND — The International Cardio-Oncology Society has awarded University Hospitals (UH) Harrington Heart & Vascular Institute a Center of Excellence designation in recognition of its ongoing support of cancer patients facing heart...
CLEVELAND — The International...
02/02/2023
Cath Lab Digest
News
02/02/2023
Rather than myosin proteins that make up thick filaments automatically finding their way to thin filaments when their targets were activated, the researchers discovered that myosin motor proteins have to be turned on before they can generate...
Rather than myosin proteins that make up thick filaments automatically finding their way to thin filaments when their targets were activated, the researchers discovered that myosin motor proteins have to be turned on before they can generate...
Rather than myosin proteins that...
02/02/2023
Cath Lab Digest
News
02/02/2023
Cagent Vascular, the exclusive developer of Serration Angioplasty (Serranator®), announced the results of a comparative sub-analysis of the PRELUDE-Below-the-Knee (BTK) study versus Plain Old Balloon Angioplasty (POBA).
Cagent Vascular, the exclusive developer of Serration Angioplasty (Serranator®), announced the results of a comparative sub-analysis of the PRELUDE-Below-the-Knee (BTK) study versus Plain Old Balloon Angioplasty (POBA).
Cagent Vascular, the exclusive...
02/02/2023
Cath Lab Digest
News
02/01/2023
HOUMA, LA – February 1, 2023 – Cardiovascular Institute of the South (CIS), one of the largest independent cardiovascular practices in the country, announced the launch of a national cardiovascular platform, Cardiovascular Logistics, in...
HOUMA, LA – February 1, 2023 – Cardiovascular Institute of the South (CIS), one of the largest independent cardiovascular practices in the country, announced the launch of a national cardiovascular platform, Cardiovascular Logistics, in...
HOUMA, LA – February 1, 2023 –...
02/01/2023
Vascular Disease Management
News
02/01/2023
The survey – which was conducted online among more than 2,000 Americans age 18 and older – found 47% of those under age 45 don’t think they are at risk for heart disease.
The survey – which was conducted online among more than 2,000 Americans age 18 and older – found 47% of those under age 45 don’t think they are at risk for heart disease.
The survey – which was conducted...
02/01/2023
Cath Lab Digest
News
01/31/2023
The updated guidelines, which modify the previous 2014 guidelines by no longer restricting recommended treatment to facilities with on-site surgical backup, will now endorse expanded treatment options and access for patients with calcified...
The updated guidelines, which modify the previous 2014 guidelines by no longer restricting recommended treatment to facilities with on-site surgical backup, will now endorse expanded treatment options and access for patients with calcified...
The updated guidelines, which...
01/31/2023
Cath Lab Digest
News
01/31/2023
Researchers analyzed data from more than a half million people between the ages of 18 and 49.
Researchers analyzed data from more than a half million people between the ages of 18 and 49.
Researchers analyzed data from...
01/31/2023
Cath Lab Digest
News
01/30/2023
The statement explains that adequate operator experience, appropriate clinical judgment and case selection, and facility preparation are essential to a safe and successful PCI program with no-SOS.
The statement explains that adequate operator experience, appropriate clinical judgment and case selection, and facility preparation are essential to a safe and successful PCI program with no-SOS.
The statement explains that...
01/30/2023
Cath Lab Digest
News
01/30/2023
XyloCor Therapeutics announced completion of the Phase 2 portion of its clinical trial (EXACT) to assess safety and preliminary evidence of efficacy of gene therapy candidate XC001 in patients with refractory angina.
XyloCor Therapeutics announced completion of the Phase 2 portion of its clinical trial (EXACT) to assess safety and preliminary evidence of efficacy of gene therapy candidate XC001 in patients with refractory angina.
XyloCor Therapeutics announced...
01/30/2023
Cath Lab Digest
News
01/27/2023
A video-based deep learning model successfully predicted scores of zero in patients with good health as well as high coronary calcium scores, likely foreshadowing a worse future prognosis.
A video-based deep learning model successfully predicted scores of zero in patients with good health as well as high coronary calcium scores, likely foreshadowing a worse future prognosis.
A video-based deep learning...
01/27/2023
Cath Lab Digest

Advertisement

Advertisement

Advertisement